
Our Posters & Publications
AHA 2020
Comparison of Net Clinical Benefit between Clopidogrel-based and ticagrelor-based Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention in China
ISPOR Europe 2019
COST-EFFECTIVENESS OF DACOMITINIB VS. GEFITINIB AS FIRST-LINE TREATMENT FOR EGFR-MUTATION POSITIVE ADVANCED NON-SMALL-CELL LUNG CANCER IN CHINA
​
Data Quality Evaluation of 5 Municipal and Provincial Claims Databases of Fujian Province, China
EFFECTS OF STATIN THERAPY ON LONG-TERM HEALTH CARE OUTCOMES AND MEDICAL COST BASED ON REGIONAL HEALTH INSURANCE CLAIM DATABASE
COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS VS. ON DEMAND TREATMENT FOR HAEMOPHILIA B CHILDREN WITHOUT INHIBITOR IN CHINA
ISPOR Asia Pacific Japan 2018
COST-EFFECTIVENESS OF DACOMITINIB VS. GEFITINIB AS FIRST-LINE TREATMENT FOR EGFR-MUTATION POSITIVE ADVANCED NON-SMALL-CELL LUNG CANCER IN CHINA
RATE OF HYPOGLYCEMIC EVENTS IN PATIENTS USING BASAL INSULIN ANALOGUES: A REAL WORLD ANALYSIS OF FOUR GRADE III CLASS A HOSPITALS IN CHINA
ISPOR 2018
COMPARATIVE COSTS AND CLINICAL EFFECTIVENESS AMONG PATIENTS WITH CORONARY HEART DISEASE BY THE USE OF 5-ISMN OR ISDN: A REAL-WORLD DATA ANALYSIS
ISPOR USA 2017
Effectiveness and economic efficiency of the treatment of coronary heart disease with salvianolate injection: A retrospective cohort study
01
A Multicenter Retrospective Analysis on Clinical Effectiveness and Economic Assessment of Compound Reserpine and Hydrochlorothiazide Tablets (CRH) for Hypertension
(DOI: 10.2147/CEOR.S231210)
03
Comparative analysis of cost–effectiveness between isosorbide-5-mononitrate and isosorbide: a retrospective real-world evaluation
(DOI: 10.2217/cer-2019-0099)
05
Comparative analysis of cost–effectiveness between isosorbide-5-mononitrate and isosorbide_ a retrospective real-world evaluation
(DOI: 10.2217/cer-2019-0099)
07
The prescription patterns and safety profiles of oral non-steroidal anti -inflammatory drugs in China an 8-year real-life analysis
(DOI: 10.21037/apm-20-2356)
02
Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis
(DOI: 10.2217/cer-2017-0063)
04
China county based COPD Screening and cost-effectiveness analysis
(DOI: 10.21037/apm-21-812)
06
Crizotinib versus chemotherapy: a real-world cost–effectiveness study in China
(DOI: 10.2217/cer-2019-0075)
08